Search results
Order by most recent / most popular / relevance
Results: 1-10 of 197
Judicial review brought outside time period and no vested right to NOC
- Borden Ladner Gervais LLP
- -
- Canada
- -
- January 23 2013
This decision relates to the consideration by the Minister of Health of Apotex’ submission for a Notice of Compliance (NOC) for omeprazole magnesium
Trial Judge's findings of anticipation and obviousness upheld on appeal
- Borden Ladner Gervais LLP
- -
- Canada
- -
- January 23 2013
This is an appeal of a patent infringement decision. The Court found the patent invalid for anticipation and obviousness. The Court of Appeal held
Hershkovitz v. Tyco safety Products Canada Ltd
- Borden Ladner Gervais LLP
- -
- Canada
- -
- August 4 2010
Hershkovitz appealed a decision of the Federal Court holding that its patent was invalid
Picard v. Commissioner of Patents
- Borden Ladner Gervais LLP
- -
- Canada
- -
- August 4 2010
This is an official translation of a decision released in January 20, 2010
Eli Lilly Canada v. Novopharm Limited
- Borden Ladner Gervais LLP
- -
- Canada
- -
- August 4 2010
The Court of Appeal overturned the decision of the trial judge which held that the patent was invalid
Industry news
- Borden Ladner Gervais LLP
- -
- Canada
- -
- December 21 2010
The Canadian Intellectual Property Office is holding a consultation period from December 7, 2010 to January 20, 2011 regarding proposed Practice Notices for RegistrationRecordal of assignments and other transfers, and Correction of assignment-related information on the Patent Office and Industrial Design Office records
Pfizer v. Ratiopharm
- Borden Ladner Gervais LLP
- -
- Canada
- -
- August 11 2010
The Court of Appeal dismissed Pfizer's appeal from a Trial Judge decision finding the patent at issue to be invalid
Generic association does not have standing to challenge listing on register of innovative drugs
- Borden Ladner Gervais LLP
- -
- Canada
- -
- December 21 2010
The Canadian Generic Pharmaceutical Associate (CGPA) brought a judicial review application in respect of the listing of Avamys on the Register of Innovative Drugs (Register
Other IP industry news of note
- Borden Ladner Gervais LLP
- -
- Canada
- -
- August 25 2010
The amendments to the Federal Court Rules regarding expert witnesses have been published into law (starting at pg 1547
Astrazeneca v. Apotex
- Borden Ladner Gervais LLP
- -
- Canada
- -
- August 25 2010
The Court found the allegations of invalidity as to lack of sound prediction of utility and of obviousness justified and dismissed the application
Current Search
- Jurisdiction - Canada
- Author - Beverley Moore
- Workarea - Patents